Equities research analysts at StockNews.com assumed coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Get Free Report) in a report issued on Sunday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock.
Agile Therapeutics Stock Performance
AGRX stock opened at $1.46 on Friday. The stock has a market capitalization of $10.01 million, a P/E ratio of -0.40 and a beta of 1.58. Agile Therapeutics has a 12 month low of $0.20 and a 12 month high of $2.63. The firm has a 50-day moving average price of $1.20 and a 200-day moving average price of $0.80.
Agile Therapeutics (NASDAQ:AGRX – Get Free Report) last issued its quarterly earnings data on Monday, August 12th. The specialty pharmaceutical company reported ($0.68) earnings per share (EPS) for the quarter. The company had revenue of $5.58 million for the quarter.
Institutional Inflows and Outflows
About Agile Therapeutics
Agile Therapeutics, Inc, a women's healthcare company, engages in the research, development, and commercialization of prescription contraceptive products for women in the United States. It offers Twirla, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen.
See Also
- Five stocks we like better than Agile Therapeutics
- What Are Dividend Achievers? An Introduction
- Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
- What is a Bond Market Holiday? How to Invest and Trade
- 2 Option Strategies to Maximize Profits in a Bear Market
- What is the NASDAQ Stock Exchange?
- Lululemon Stock Gears Up for a Massive Comeback Rally
Receive News & Ratings for Agile Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agile Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.